Eisai — Drug Prices & Medicare Spending

Eisai manufactures 6 drugs tracked by Medicare Part D with total spending of $1.9B.

Drugs Tracked

$1.9B

Medicare Spending

$96.07

Avg Cost/Claim

100%

Have Generics

Eisai Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Lenvima	Lenvatinib	$11,526.00	$876.0M	+14.2%	Yes
2	Dayvigo	Lemborexant	$185.00	$345.0M	+42.6%	Yes
3	Fycompa	Perampanel	$552.00	$234.0M	+6.8%	Yes
4	Aricept	Donepezil	$21.00	$178.0M	-42.4%	Yes
5	Donepezil	Donepezil Hydrochloride	$17.00	$145.0M	-28.4%	Yes
6	Banzel	Rufinamide	$831.00	$123.0M	-8.4%	Yes

Eisai manufactures 6 drugs tracked by Medicare Part D, with total annual spending of $1.9B.

Lenvima (Lenvatinib) is the most expensive at $11,526.00 per claim.

6 of 6 Eisai drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.